Oral tissues are constantly exposed to damage from the mechanical effort of eating and from the invasion of foreign microorganisms such as bacteria, fungi, and virus. In healthy oral tissues, there is a balance between symbiotic bacteria and cells from the innate immune system, mainly neutrophils. When this balance is broken, inflammation appears and more immune cells are recruited to the gingiva. Neutrophils form a barrier against dysbiotic bacteria. However, when neutrophils are insufficient, bacteria thrive causing periodontitis, a chronic inflammatory disease that destroys the tooth‐supporting tissues or periodontium. Damage of periodontal tissues leads to tooth loss, and in severe cases, it can also affect systemic health by increasing a person's risk for atherosclerosis, rheumatoid arthritis, diabetes, and even cancer. The mechanisms neutrophil employ to keep a balance with bacteria in order to maintain healthy oral tissues is the focus of this chapter. We discuss how neutrophil antimicrobial functions keep bacteria at check and how some dysbiotic bacteria block neutrophils to promote an inflammatory state. Also, novel therapeutic approaches for periodontitis are discussed.
- oral microbiota
- dysbiotic microbiota
Periodontal disease is a major public health problem due to its high prevalence worldwide . Periodontitis is a more advanced inflammatory form of periodontal disease. It is a chronic inflammatory disease that causes tooth loss, by destroying the periodontium. Periodontal destruction may be caused by different factors, including accumulation of dental biofilm, poor oral hygiene, and loss of balance between oral microbiota and immune response. Dysbiosis (an alteration of oral microbiota) is thought to be the initial trigger for periodontitis . The accumulation of bacteria biofilm leads to an increase in the inflammatory infiltrate, composed mainly by neutrophils into oral tissues. In this chapter, we will discuss the role of neutrophils in periodontal disease.
2. Neutrophil homeostasis
Neutrophils are considered to be the first line of defense during infections and inflammation . They are the most abundant leukocytes in blood and can live for much longer than previously thought. It is estimated that neutrophils half‐life is days instead of hours . When microorganisms invade the organism, an inflammatory response is induced. Neutrophils are recruited from the circulation into the tissues where they destroy microorganisms by phagocytosis, by releasing antimicrobial substances, or by NETosis (Figure 1). This last mechanism was recently discovered and consists on the formation of neutrophil extracellular traps (NETs) . Activated neutrophils produce a variety of chemokines and cytokines, directing the inflammatory and the immune responses . Unfortunately, if there is not a proper clearance of neutrophils after an infection, the proteases released from neutrophils into the surrounding tissue can cause damage to the host . Bacteria biofilm deposited on teeth induces a constant recruitment of neutrophils (>95%) to the gingival sulcus (Figure 2) [8, 9]. Therefore, neutrophil homeostasis is important to prevent collateral damage to the host by the potent proinflammatory and antimicrobial effects of these cells. As neutrophils are the most abundant leukocytes, their excess or absence in the mouth leads to periodontal tissue damage. Moreover, neutrophil distribution and numbers are essential in maintaining oral health. Neutrophil homeostasis involves production, trafficking, and clearance of these cells .
Thousands of neutrophils are daily produced in the bone marrow and released into the circulation . Three pools of neutrophil population reside in the bone marrow: the stem cell pool, the mitotic pool, and the postmitotic pool (Figure 1A). The first pool consists of undifferentiated pluripotent hematopoietic stem cells (HSCs), the second pool consists of committed granulocytic progenitor cells that proliferate and differentiate. Finally, the third pool consists of fully differentiated neutrophils, which form the bone marrow reserve, available for release . HSCs differentiate into myeloblasts, a developmental cell type committed to becoming granulocytes (Figure 1A). Granulocyte colony‐stimulating factor (G‐CSF) regulates both, production or granulopoiesis, and neutrophil release from the bone marrow. G‐CSF regulates granulopoiesis by inducing proliferation of granulocytic precursors in the bone marrow . A large postmitotic pool is retained in the bone marrow by the interaction of CXC chemokine receptor 4 (CXCR4) on neutrophils with chemokine CXCL12 (stromal‐derived factor‐1/SDF‐1) produced by bone marrow stromal cells (Figure 1A). G‐CSF regulates mature neutrophil release from the bone marrow by interfering with the CXCR4‐CXCL12 interaction . In addition, interleukin‐17 (IL‐17) endorses granulopoiesis and neutrophil release by upregulation of G‐CSF (Figure 1) . IL‐17 builds on an interesting positive loop of neutrophil recruitment. For example, in chronic inflammation sites, neutrophils produce IL‐17 and can also attract IL‐17‐producing CD4+ T lymphocytes (Th17 cells) . Neutrophils also release CCL20 and CCL2 chemokines, which are ligands for CCR6 and CCR2 chemokine receptors, respectively, on Th17 cells. This interaction maintains Th17 cells at inflammation sites. Therefore, Th17 cells secrete more IL‐17 and more neutrophils are recruited .
Circulating neutrophils can be quickly mobilized to infection or inflammation sites through a systematically controlled process known as the leukocyte adhesion cascade, which achieves neutrophil transmigration (Figure 1B) . The process initiates when endothelial cells get activated and upregulated the expression of adhesion receptors such as E‐ and P‐selectins. Neutrophils recognize these selectins and begin rolling on endothelial cells. This rolling depends on transient interactions of selectins with glycoprotein ligands on neutrophils. Next, neutrophils get activated by chemokines, which induce a high affinity state in integrins, another group of adhesion receptors. Interaction of both selectins and integrins with their corresponding ligands leads to slow neutrophils rolling followed by a firm adhesion that brings neutrophils to a full stop. Finally, neutrophils crawl on the endothelium and transmigrate into infection or inflammation sites. This last process is regulated mainly by β2 integrins. Integrins are heterodimeric receptors formed by a unique α (CD11) and a common β (CD18) subunit that interact with adhesion ligands such as intercellular adhesion molecule‐1 (ICAM‐1) and ICAM‐2 on endothelial cells (Figure 1B). This leukocyte adhesion cascade is positive regulated by tissue‐derived cytokines and by tissue‐derived chemokines. Cytokines control the expression of endothelial adhesion molecules and chemokines induce integrins to change conformation into a high affinity state . Once neutrophils move into tissues, they follow chemoattractant gradients to reach infection or inflammation sites. Some chemoattractants for neutrophils are activated by complement components, such as the anaphylatoxin C5a, and bacterial components, such as formyl‐methionyl‐leucyl‐phenylalanine (fMLF). Recently, it has been discovered that the leukocyte adhesion cascade is also negatively regulated by endogenous inhibitors such as Del‐1 (developmental endothelial locus‐1), pentraxin 3, and growth‐differentiation factor 15 .
Neutrophils are mostly cleared in tissues (Figure 1C) and possibly also in the bone marrow (Figure 1A). In tissues, once neutrophils have completed their antimicrobial duty, they undergo apoptosis. Resident phagocytes, for instance, macrophages and dendritic cells, clear neutrophils locally. Phagocytosis of apoptotic neutrophils reprograms macrophages to initiate an anti‐inflammatory response, characterized by the synthesis of tumor growth factor (TGF)‐β and IL‐10, and by a reduction in IL‐23 synthesis (Figure 1) . IL‐23 cytokine induces IL‐17 synthesis; thus, the reduced IL‐17 levels lead to less G‐CSF production and in consequence, less neutrophil production. This process is a control loop that has been described as a “neutrostat” (neutrophil rheostat), and maintains steady‐state neutrophil levels (Figure 1) . Senescent circulating neutrophils are recruited for clearance in the bone marrow. These neutrophils increase the expression of CXCR4, and respond to CXCL12 by homing back to the bone marrow (Figure 1) . Apoptosis and proper removal of apoptotic cells are key aspects of inflammation resolution. Neutrophils death is influenced by environmental conditions including hypoxia and presence of inflammatory mediators, such as granulocyte/monocyte colony‐stimulating factor (GM‐CSF) and lipopolysaccharides (LPS). Neutrophil clearance depends on signals that apoptotic neutrophils express on their surface. These signals allow macrophages to recognize and ingest the neutrophils (Figure 1C) . Failure to clear these apoptotic cells results in secondary necrosis and release of products that generate proinflammatory signals. Neutrophils express molecules that regulate their survival. Some of these molecules are survivin, cyclin‐dependent kinases and proliferating cell nuclear antigen (PCNA). Survivin is expressed more highly in immature neutrophils than in mature ones, but its expression can be reestablished in mature cells by inflammatory signals, for instance, GM‐CSF or G‐CSF . Similarly, cyclin‐dependent kinases function as prosurvival factors. Their inhibition induces caspase‐dependent apoptosis. PCNA in neutrophils associates with procaspases in the cytosol and is thought to prevent their activation. During apoptosis, PCNA is targeted for proteosomal degradation, which correlates with an increase in caspase‐3 and caspase‐8 activities .
3. Neutrophils in oral health
Commonly, it is thought that microbes are harmful to our health. Contrary to this thought, there are plenty of microbes that harmoniously live within our bodies and form our microbiota. Homeostasis between the host and its symbiotic microbiota is a key factor to understand and maintain our health [22, 23]. Nevertheless, we are constantly exposed to microbes not belonging to our microbiota through the things we touch, the food we eat, and the air we inhale. Fortunately, our innate immune system protects us from this constant threat. The oral cavity is a special place, where the microbiota is constantly changing. Yet, homeostatic mechanisms exist that keep the oral microbiota in balance with the immune system. Neutrophils are actively recruited into the gingival sulcus by an interleukin (IL)‐8 gradient continuously secreted by the junctional epithelium, as this tissue is in close contact with the oral biofilm bacterial community (Figure 2). Neutrophils are mostly responsible for ensuring periodontal health by keeping this biofilm at check . However, during gingivitis a moderate inflammatory response is generated. If this inflammation is not controlled, for example, in situations or poor oral hygiene, gingivitis can lead to periodontitis, a chronic inflammatory disease. In this condition, microbial pathogens cannot be eliminated or controlled by neutrophils. In response, more neutrophils are recruited to the periodontal tissue. Neutrophil accumulation, instead of protecting, favors periodontal tissue damage and even bone loss (Figure 2). Thus, a close balance between neutrophil function and microbe challenge must be maintained to ensure periodontal health.
4. Antimicrobial mechanisms of neutrophils
Neutrophils are equipped with different antimicrobial mechanisms, which help them to fight a broad spectrum of bacteria, fungi, and protozoa. These mechanisms include phagocytosis, degranulation, and neutrophil extracellular traps (NETs) (Figure 1).
Phagocytosis is a receptor‐mediated process during which a particle is internalized by the cell into a vacuole called the phagosome. Neutrophils recognize pathogens through pattern‐recognition receptors (PAMPs), or opsonins (antibody molecules or complement components). Opsonized pathogens are efficiently phagocytosed when they bind with antibody receptors (Fc receptors) or complement receptors on the neutrophil (Figure 3). After engulfment, the nascent phagosome matures by fusing with lysosomes. This brings antimicrobial molecules into the phagosomal lumen. The vesicle is now called phagolysosome. Concurrently, reactive oxygen species (ROS) production starts by the assembly of the NADPH oxidase on the phagosomal membrane, and the pH inside the phagosome drops to 4.5–5. Also, potassium ions (K+) are pumped into the phagolysosome; this K+ influx mediates the release of serine proteases. In addition, hydrogen peroxide (H2O2) is also converted into hypochloric acid (HOCl) in a reaction catalyzed by myeloperoxidase (MPO) . Granules content and ROS create an environment toxic to the pathogen. Unfortunately, not all pathogens are killed inside the phagosome. Moreover, some have advanced strategies to survive inside neutrophils. These strategies include interfering with engulfment, modulating phagosome maturation, and creating a more hospitable intraphagosomal environment.
In the bone marrow, as precursor cells mature into neutrophils, they synthesize proteins that are sorted into different granules . Granules formation begins in early promyelocytes and continues throughout the various stages of myeloid cell development. The granules are arbitrarily subdivided into three different classes based on their resident cargo molecules: azurophilic, specific, and gelatinase granules (Figure 1A, Table 1). Neutrophils also form secretory vesicles until the last step of their differentiation (Figure 1A, Table 1). Granule heterogeneity is explained by regulated expression of the granule protein genes. This regulation is mediated by the combination of myeloid transcription factors that express at specific stages of neutrophil development. Vesicle availability and exocytosis depends on mobilizable intracellular compartments of the neutrophil. Mature neutrophils are released into the circulation and, in response to infection, they leave the circulation and migrate toward the inflammatory site. Exocytosis of granules and secretory vesicles plays a crucial role in most neutrophil functions from early activation to the destruction of phagocytosed microorganisms. Secretory vesicles have the highest propensity for extracellular release, followed by gelatinase granules, specific granules, and azurophil granules [27, 28]. For example, neutrophil stimulation with phorbol myristate acetate (PMA) induces complete release of gelatinase granules, restrained release of specific granules, and minimal exocytosis of azurophil granules. In a different way, neutrophil stimulation with fMLF induces release of mostly secretory vesicles without significant release of granules. The hierarchical mobilization of neutrophil granules and secretory vesicles depends on intracellular Ca2+ level. Gradual elevations in intracellular Ca2+ are induced by ligation of L‐selectin, CD11b/CD18, and the fMLP receptors .
|Azurophil granules||Specific granules||Gelatinase granules||Secretory vesicles|
|Bacterial/permeability‐increasing protein||Cathelicidin||CD11b/CD18||CD11b/CD18 (CR3)|
|Myeloperoxidase||Leukolysin||Natural‐resistance‐associated macrophage protein 1 (NRAMP1)||FRP|
|Natural serine proteases||Lysozyme||fMLF-R|
|Cathepsin G||Neutrophil gelatinase‐associated lipocalin (NGAL)|
4.3. Neutrophil extracellular traps (NETs)
Neutrophil stimulation can also undergo a mechanism called NETosis. Although NETosis has previously been described as a special form of programmed cell death, there are forms of NET production that do not end with the demise of neutrophils. NETosis leads to the release of decondensed chromatin into the extracellular space. The chromatin forms a trap for pathogens that looks like a net, which is why they are called neutrophil extracellular traps (NETs). NETs also contain histones, cytoplasmic proteins, and antimicrobial granular molecules. NETs formation mechanisms are still unknown, nevertheless, NADPH oxidase activation, reactive oxygen species (ROS) production, myeloperoxidase (MPO), and neutrophil elastase (NE) release (Figure 3) are required .
5. Neutrophil interactions with symbiotic oral bacteria
In periodontal health, the interaction between symbiotic microbial community and neutrophils is strongly controlled to prevent tissue damage. This interaction has been evaluated in studies with germ‐free mice and specific pathogen‐free mice. Results of these studies showed that oral symbiotic commensal microbiota has no impact on the structure of gingival tissue of germ‐free mice, while gut commensal microbiota is fundamental on the structural formation of the intestinal tissue . Periodontal tissue recruits neutrophils by means of the chemotactic receptor CXCR2. This receptor has two ligands CXCL1 and CXCL2. Both ligands are expressed in the junctional epithelium of germ‐free and specific pathogen‐free mice, but there is a significant increase on CXCL2 in the epithelium of specific pathogen‐free mice. Therefore, oral bacterial community induces an increase in neutrophil recruitment via CXCL2 . Neutrophils play a key role in preserving oral health, since low neutrophil counts as well as deficiency in neutrophil functional responses have been associated with periodontal disease. As mentioned before, neutrophils kill pathogens by phagocytosis, degranulation, or NETs formation (Figure 1C). Neutrophils are very efficient phagocytic cells and have a very efficient antimicrobial mechanism to do so, the respiratory burst response. In this response, high consumption of oxygen results in the production of reactive oxygen species (ROS), through the activation of the NADPH oxidase complex (Figure 3) . Patients with chronic granulomatous disease, a rare genetic disorder that consist on mutations in the NADPH oxidase, are inefficient in mounting a respiratory burst response. As a consequence, these patients present early in life recurrent infections . These patients present higher bacteria colonization and gingivitis; however, they do not present periodontitis .
6. The evolution from a healthy periodontium to periodontitis
In the oral cavity, the tooth surface offers a niche for bacteria colonization and biofilm formation resulting in a varied polymicrobial community. A healthy environment is maintained if the multiplication of symbiotic microbiota is regulated. Periodontal diseases are related to a shift from symbiotic microbiota to dysbiotic microbiota, and this shift is related with the accumulation of dental plaque or biofilm. Biofilm elaboration consists of four sequential phases. Phase 1 consists of the adsorption of different molecules to a surface to condition the biofilm formation. Phase 2 consists of single organism adhesion. Phase 3 consists of growth of extracellular matrix production and multiplication of adhering bacteria and phase 4 consists of sequential adsorption of further bacteria to form a more complex and mature biofilm (Figure 4) . The microbial etiology of gingivitis and periodontitis has been established for several decades. In 1994, Haffajee and Socransky adapted Koch's postulates to be used in the identification of periodontal pathogens. In 1996, at the World Workshop in Periodontics three species of pathogens were identified as causative factors of periodontitis
6.1. Balanced inflammation
Neutrophils are the main leukocytes recruited to the gingival sulcus. Neutrophils exit the gingival blood vessels and travel through the gingival junctional epithelium until they reach the sulcus . In the sulcus, neutrophils create a barrier against the growing bacteria biofilm to prevent bacteria from invading the underlying tissues. Neutrophil migration from vessels toward the gingival sulcus requires CXCR2 binding to CXCL2. Migration is controlled by gradients of chemokines and adhesion molecules such as IL‐8, ICAM‐1, and E‐selectin . Neutrophil presence in the sulcus is necessary to preserve oral health since patients with altered neutrophil production and distribution develop severe periodontitis at early ages . Chédiak‐Higashi syndrome, Papillon‐Lefèvre syndrome, neutropenias, and leukocyte adhesion deficiency (LAD) are some examples of neutrophil diseases. In Papillon‐Lefèvre syndrome neutrophils have defective chemotaxis, as a consequence, they are not efficiently recruited to the sites of inflammation and infection . Neutropenia, a persistent reduction of neutrophil numbers in circulation, is frequently associated with susceptibility to infections. In many neutropenic conditions, severe periodontal disease is recurrently seen since primary dentition eruption . CXCR2‐deficient mice cannot recruit neutrophils to oral tissues. These mice also experience periodontitis and periodontal bone loss early in life . Leukocyte adhesion deficiency is a group of inherited disorders, in which neutrophils fail to transmigrate from the circulation to the site of inflammation or infection. Neutrophils of patients with leukocyte adhesion deficiency have defective expression and function of adhesion molecules like integrins. Therefore, neutrophils cannot adhere firmly to the vascular endothelium to transmigrate. Even though the presence of neutrophils is necessary to control infections, plenty of neutrophils on a site of infection is not always protective. In fact, neutrophil numbers in inflamed periodontal tissues correlate with the severity of the lesions , and tissue destruction seems to be a collateral damage of hyperactive neutrophils .
Periodontal diseases cause the destruction of the tooth supporting tissues, gingiva, periodontal ligament, cement, and alveolar bone and may eventually lead to tooth loss. Severe periodontitis affects approximately 10% of the global population . Periodontal disease is the consequence of a shift in oral microbiota population from a symbiotic to a dysbiotic microbial community in the mouth. Periodontal disease begins when some factors that promote the growth of selected symbiotic bacteria, induce host inflammatory pathways [40, 41]. Periodontitis not only severely deteriorates people's quality of life by impairing the dentition but also adversely affect systemic health. A clear correlation between periodontal disease and atherosclerosis has been established in clinical observations and in animal models. In particular, polymicrobial infection with
6.3. Inflammation in periodontitis
Periodontitis is associated with a change in oral microbiota from symbiotic bacteria to dysbiotic anaerobic microorganisms, which have adapted to succeed in an inflammatory environment (Figure 4). Pathogenic bacteria, such as
Neutrophils can be found in large numbers in inflamed periodontal tissues, and their presence correlates with the severity of the periodontal destruction. Therefore, this destruction seems to be collateral damage of hyperactive neutrophils [48, 49]. Neutrophil recruitment is at least in part regulated by Del‐1 and LFA‐1 interactions. Del‐1 blocks LFA‐1 binding to its ligand ICAM‐1 and prevents neutrophil transmigration . Neutrophil recruitment is also triggered with elevated IL‐17 levels, which resulted to be responsible for the tissue damage, because antibodies against IL‐17 prevented inflammation and bone loss. High levels of IL‐17 could be responsible for the bone loss in chronic periodontitis, by stimulating osteoblast expression of RANKL, an important osteoclastogenesis factor.
6.4. Dysbiotic bacteria
Diverse environments present in the oral cavity allow symbiotic and dysbiotic microbiota to find the best niche that fits their growth requirements, resulting in the formation of unique microbial biofilm communities. Periodontal disease microbiota includes a large number of microorganisms including
In a healthy gingival tissue, the local symbiotic microbiota is less diverse and rich, with neutrophil recruitment to clear the infection and resolving the inflammation with no collateral damage to the host (Figures 4 and 5). The progression from health to periodontitis is now explained as the transition from a symbiotic microbiota to a polymicrobial dysbiotic microbiota. Several risks factors, such as smoking, tissue injury, diet changes, an immunocompromised host, or the colonization of the oral cavity by pathogenic bacteria can modify the oral ecosystem resulting in a dysbiotic polymicrobial community. In consequence, the host's response toward the polymicrobial dysbiotic microbiota challenge is more robust and not regulated, transitioning from a controlled/stable immune response into a nonresolving chronic inflammatory response .
Polymicrobial dysbiotic microbiota has an arsenal of self‐defense mechanisms, which can be directed to attack against neutrophils or camouflage the biofilm (Figure 5) . Microbiota has an intermicrobial communication called quorum sensing, that enables the dysbiotic microbiota to optimize the biofilm conditions and ensure nutrient supply. Among the defense mechanisms, the production of bacterial surfactants by
9. Neutrophil persistence and chronic inflammation
Neutrophils are recruited to infection and inflammation sites by different chemoattractants such as interleukin 8 (IL‐8), complement fragment C5a, or chemokine CXCL5. They migrate through the junctional epithelium and finally arrive in the gingival sulcus and in gingival crevicular fluid. Neutrophils in saliva retain their phagocytic function, and their ability to generate ROS [71, 72]. NETs containing trapped bacteria have been described within the gingival sulcus, in purulent periodontal pockets, and on the surface of gingival epithelial cells. On condition that neutrophils and NETs do not occur excessively and are rapidly cleared, relatively little damage to the adjacent tissues is induced. Nevertheless, it has been widely reported that neutrophils can be responsible for both host defense and host tissue damage. Release of proteolytic and collagenolytic enzymes as well as ROS within host tissues, often lead to extracellular matrix degradation and persistent inflammation, are the main causes of tissue damage. Normally, connective tissue is degraded to allow fast transmigration of neutrophils and other cells involved in wound healing but during periodontitis it produces a chronic inflammatory disease. Hence, inflammation overweighs resolution, and host tissue destruction becomes progressive, eventually resulting in pathological osteolysis and tooth loss .
10. Therapeutic approaches
As it was discussed along this chapter, it is clear that both, lack of neutrophils and excess of neutrophils in the periodontium, can lead to periodontal disease. Because both situations involve IL‐17‐mediated inflammation and bone loss, it is conceivable that IL‐17 or IL‐17R inhibitors may be promising targets for treatment of human periodontitis. By blocking IL‐17 actions, neutrophil recruitment to the periodontium would be reduced and in consequence, the inflammation state would also be reduced. This should prevent tissue damage and loss of bone.
In chronic periodontitis, periodontal bacteria activate neutrophil subversion pathways that allow bacteria to escape neutrophil killing. For example,
Del‐1 is another promising candidate molecule to be used therapeutically to prevent neutrophil recruitment and bone loss associated with periodontal inflammation . Since Del‐1 blocks LFA‐1 binding to its ligand ICAM‐1 and prevents neutrophil transmigration , it could be administered to inflamed tissues, to reduce neutrophil recruitment, and to reduce inflammation. In fact, this is exactly what was found in a model of periodontitis with nonhuman primates . Local administration of Del‐1 also prevented inflammatory bone loss . Preclinical studies for the use of Del‐1 are now underway.
All these potential therapeutic approaches promise a relief from periodontitis and perhaps other inflammatory disorders in the future.
Neutrophils are specialized phagocytes that coordinate and execute inflammation. Neutrophils constantly surveil oral tissues in order to guarantee oral health. Alterations in the neutrophil homeostasis (defects in recruitment and proper function) lead to periodontal diseases. Also, hyperactive neutrophils can exacerbate and even cause autoimmune and inflammatory diseases. Chronic infections driven by pathogenic biofilms indicate that the immune system fails to fully protect the host. New potential therapeutic approaches have been identified. They promise a relief from periodontitis and perhaps other inflammatory disorders.
This work was supported by Grant 254434 from Consejo Nacional de Ciencia y Tecnología, México (to Carlos Rosales), and by Grant PAPIIT IA202013 (to Eileen Uribe‐Querol) from Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México, Mexico.
Petersen PE, Ogawa H: The global burden of periodontal disease: towards integration with chronic disease prevention and control. Periodontol. 2000 2012; 60:15–39. DOI: 10.1111/j.1600‐0757.2011.00425.x.
Rosier BT, De Jager M, Zaura E, Krom BP: Historical and contemporary hypotheses on the development of oral diseases: are we there yet? Front. Cell. Infect. Microbiol. 2014; 4:92. DOI: 10.3389/fcimb.2014.00092
Borregaard N: Neutrophils, from marrow to microbes. Immunity 2010; 33:657–670. DOI: 10.1016/j.immuni.2010.11.011
Tak T, Tesselaar K, Pillay J, Borghans JA, Koenderman L, Tesselaar K, Pillay J, Borghans JA, Koenderman L: What's your age again? Determination of human neutrophil half‐lives revisited. J. Leukoc. Biol. 2013; 94:595–601. DOI: 10.1189/jlb.1112571
Nauseef WM: How human neutrophils kill and degrade microbes: an integrated view. Immunol. Rev. 2007 219:88–102. DOI: 10.1111/j.1600‐065X.2007.00550.x
Mócsai A: Diverse novel functions of neutrophils in immunity, inflammation, and beyond. J. Exp. Med. 2013; 210:1283–1299. DOI: 10.1084/jem.20122220.
Mayadas TN, Cullere X, Lowell CA: The multifaceted functions of neutrophils. Annu. Rev. Pathol. 2014; 9:181–218. DOI: 10.1146/annurev‐pathol‐020712‐164023
Hajishengallis E, Hajishengallis G: Neutrophil homeostasis and periodontal health in children and adults. J. Dent. Res. 2014 93:231–237. DOI: 10.1177/0022034513507956
Delima AJ, Van Dyke TE: Origin and function of the cellular components in gingival crevice fluid. Periodontol. 2000. 2003; 31:55–76.
von Vietinghoff S, Ley K: Homeostatic regulation of blood neutrophil counts. J. Immunol. 2008; 181:5183–5188.
Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A: Neutrophil function: from mechanisms to disease. Annu. Rev. Immunol. 2012; 30:459–489. DOI: 10.1146/annurev‐immunol‐020711‐074942
Summers C, Rankin SM, Condliffe AM, Singh N, Peters AM, Chilvers ER: Neutrophil kinetics in health and disease. Trends Immunol. 2010; 31:318–324. DOI: 10.1016/j.it.2010.05.006.
Weaver CT, Elson CO, Fouser LA, Kolls JK: The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu. Rev. Pathol. 2013; 8:477–512. DOI: 10.1146/annurev‐pathol‐011110‐130318
Cortés‐Vieyra R, Rosales C, Uribe‐Querol E: Neutrophil functions in periodontal homeostasis. J. Immunol. Res. 2016; 2016:1396106. DOI: 10.1155/2016/1396106
Ley K, Laudanna C, Cybulsky MI, Nourshargh S: Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007; 7:678–689. DOI: 10.1038/nri2156
Kolaczkowska E, Kubes P: Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 2013; 13:159–175. DOI: 10.1038/nri3399
Eskan MA, Jotwani R, Abe T, Chmelar J, Lim JH, Liang S, Ciero PA, Krauss JL, Li F, Rauner M et al: The leukocyte integrin antagonist Del‐1 inhibits IL‐17‐mediated inflammatory bone loss. Nat. Immunol. 2012; 13:465–473. DOI: 10.1038/ni.2260.
Kennedy AD, DeLeo FR: Neutrophil apoptosis and the resolution of infection. Immunol. Res. 2009; 43:25–61. DOI: 10.1007/s12026‐008‐8049‐6
Martin C, Burdon PC, Bridger G, Gutierrez‐Ramos JC, Williams TJ, Rankin SM: Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity 2003; 19:583–593.
Stark MA, Huo Y, Burcin TL, Morris MA, Olson TS, Ley K: Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL‐23 and IL‐17. Immunity 2005; 22:285–294. DOI: 10.1016/j.immuni.2005.01.011
Altznauer F, Martinelli S, Yousefi S, Thürig C, Schmid I, Conway EM, Schöni MH, Vogt P, Mueller C, Fey MF et al: Inflammation‐associated cell cycle‐independent block of apoptosis by survivin in terminally differentiated neutrophils. J. Exp. Med. 2004 199:1343–1354. DOI: 10.1084/jem.20032033
Belkaid Y, Naik S: Compartmentalized and systemic control of tissue immunity by commensals. Nat. Immunol. 2013 14:646–653. DOI: 10.1038/ni.2604
Belkaid Y: Tailored immunity at mucosae. Immunol. Rev. 2014; 260:5–7. DOI: 10.1111/imr.12197
Curtis MA, Zenobia C, Darveau RP: The relationship of the oral microbiotia to periodontal health and disease. Cell Host Microbe 2011 10:302–306. DOI: 10.1016/j.chom.2011.09.008
Pham CT: Neutrophil serine proteases: specific regulators of inflammation. Nat. Rev. Immunol. 2006 6:541–550. DOI: 10.1038/nri1841
Faurschou M, Borregaard N: Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 2003; 5:1317–1327.
Sengeløv H, Follin P, Kjeldsen L, Lollike K, Dahlgren CNB: Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils. J. Immunol. 1995; 154:4157–4165.
Sengeløv H, Kjeldsen L, Borregaard N: Control of exocytosis in early neutrophil activation. J. Immunol. 1993; 150:1535–1543.
Zenobia C, Luo XL, Hashim A, Abe T, Jin L, Chang Y, Jin ZC, Sun JX, Hajishengallis G, Curtis MA et al: Commensal bacteria‐dependent select expression of CXCL2 contributes to periodontal tissue homeostasis. Cell. Microbiol. 2013 15:1419–1426. DOI: 10.1111/cmi.12127
Matute JD, Arias AA, Wright NA, Wrobel I, Waterhouse CC, Li XJ, Marchal CC, Stull ND, Lewis DB, Steele M et al: A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood 2009; 114:3309–3315. DOI: 10.1182/blood‐2009‐07‐231498
Soler‐Palacín P, Margareto C, Llobet P, Asensio O, Hernández M, Caragol I, Español T: Chronic granulomatous disease in pediatric patients: 25 years of experience. Allergol. Immunopathol. 2007; 35:83–89.
Lindhe J, Lang NP, Kariing T: Clinical Periodontology and Implant Dentistry. Vol. 1, Fifth edition. Oxford: Blackwell Munksgaard; 2008.
Zhang D, Chen G, Manwani D, Mortha A, Xu C, Faith JJ, Burk RD, Kunisaki Y, Jang JE, Scheiermann C et al: Neutrophil ageing is regulated by the microbiome. Nature 2015; 525:528–532. DOI: 10.1038/nature15367
Sørensen OE, Clemmensen SN, Dahl SL, Østergaard O, Heegaard NH, Glenthøj A, Nielsen FC, Borregaard N: Papillon‐Lefèvre syndrome patient reveals species‐dependent requirements for neutrophil defenses. J. Clin. Invest. 2014; 124:4539–4548. DOI: 10.1172/JCI76009
Roberts H, White P, Dias I, McKaig S, Veeramachaneni R, Thakker N, Grant M, Chapple I: Characterization of neutrophil function in Papillon‐Lefèvre syndrome. J. Leukoc. Biol. 2016; 100:433–444. DOI: 10.1189/jlb.5A1015‐489R
Perera NC, Wiesmüller KH, Larsen MT, Schacher B, Eickholz P, Borregaard N, Jenne DE: NSP4 is stored in azurophil granules and released by activated neutrophils as active endoprotease with restricted specificity. J. Immunol. 2013; 191:2700–2707. DOI: 10.4049/jimmunol.1301293
Uriarte SM, Edmisson JS, Jimenez‐Flores E: Human neutrophils and oral microbiota: a constant tug‐of‐war between a harmonious and a discordant coexistence. Immunol. Rev. 2016; 273:282–298. DOI: 10.1111/imr.12451
Eke PI, Dye BA, Wei L, Slade GD, Thornton‐Evans GO, Borgnakke WS, Taylor GW, Page RC, Beck JD, Genco RJ: Update on prevalence of periodontitis in adults in the United States: NHANES 2009 to 2012. J. Periodontol. 2015; 86:611–622. DOI: 10.1902/jop.2015.140520
Zadeh HH, Nichols FC, Miyasaki KT: The role of the cell‐mediated immune response to Actinobacillus actinomycetemcomitansand Porphyromonas gingivalisin periodontitis. Periodontol. 2000 1999; 20:239–288.
Borgnakke WS: Does treatment of periodontal disease influence systemic disease? Dent. Clin. North Am. 2015 59:885–917. DOI: 10.1016/j.cden.2015.06.007
Seymour GJ, Ford PJ, Cullinan MP, Leishman S, Yamazaki K: Relationship between periodontal infections and systemic disease. Clin. Microbiol. Infect. 2007; 13:3–10. DOI: 10.1111/j.1469‐0691.2007.01798.x
Rivera MF, Lee JY, Aneja M, Goswami V, Liu L, Velsko IM, Chukkapalli SS, Bhattacharyya I, Chen H, Lucas AR et al: Polymicrobial infection with major periodontal pathogens induced periodontal disease and aortic atherosclerosis in hyperlipidemic ApoE(null) mice. PLoS One 2013; 8:e57178. DOI: 10.1371/journal.pone.0057178
Daniel R, Gokulanathan S, Shanmugasundaram N, Lakshmigandhan M, Kavin T: Diabetes and periodontal disease. J. Pharm. Bioallied Sci. 2012 4:S280–S282. DOI: 10.4103/0975‐7406.100251
Lakschevitz F, Aboodi G, Tenenbaum H, Glogauer M: Diabetes and periodontal diseases: interplay and links. Curr. Diabetes Rev. 2011; 7:433–439.
Lamster IB, Pagan M: Periodontal disease and the metabolic syndrome. Int. Dent. J. 2016; 9. DOI: 10.1111/idj.12264
Dababneh R, Al‐Wahadneh AM, Hamadneh S, Khouri A, Bissada NF: Periodontal manifestation of leukocyte adhesion deficiency type I. J. Periodontol. 2008; 79:764–768. DOI: 10.1902/jop.2008.070323
Moutsopoulos NM, Konkel J, Sarmadi M, Eskan MA, Wild T, Dutzan N, Abusleme L, Zenobia C, Hosur KB, Abe T et al: Defective neutrophil recruitment in leukocyte adhesion deficiency type I disease causes local IL‐17‐driven inflammatory bone loss. Sci. Transl. Med. 2014; 6:229ra240. DOI: 10.1126/scitranslmed.3007696
Ryder MI: Comparison of neutrophil functions in aggressive and chronic periodontitis. Periodontol. 2000 2010; 53:124–137. DOI: 10.1111/j.1600‐0757.2009.00327.x
Aboodi GM, Goldberg MB, Glogauer M: Refractory periodontitis population characterized by a hyperactive oral neutrophil phenotype. J. Periodontol. 2011; 82:726–733. DOI: 10.1902/jop.2010.100508
Choi EY, Chavakis E, Czabanka MA, Langer HF, Fraemohs L, Economopoulou M, Kundu RK, Orlandi A, Zheng YY, Prieto DA et al: Del‐1, an endogenous leukocyte‐endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science 2008; 322:1101–1104. DOI: 10.1126/science.1165218
Berezow AB, Darveau RP: Microbial shift and periodontitis. Periodontol. 2000 2011 55:36–47. DOI: 10.1111/j.1600‐0757.2010.00350.x
Griffen AL, Beall CJ, Firestone ND, Gross EL, Difranco JM, Hardman JH, Vriesendorp B, Faust RA, Janies DA, Leys EJ: CORE: a phylogenetically‐curated 16S rDNA database of the core oral microbiome. PLoS One 2011 6:e19051. DOI: 10.1371/journal.pone.0019051
Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, Yu WH, Lakshmanan A, Wade WG: The human oral microbiome. J. Bacteriol. 2010; 192:5002–5017. DOI: 10.1128/JB.00542‐10
Wade WG: Has the use of molecular methods for the characterization of the human oral microbiome changed our understanding of the role of bacteria in the pathogenesis of periodontal disease? J. Clin. Periodontol. 2011; 38:7–16. DOI: 10.1111/j.1600‐051X.2010.01679.x
Hajishengallis GJLR: Dancing with the stars: how choreographed bacterial interactions dictate nososymbiocity and give rise to keystone pathogens, accessory pathogens, and pathobionts. Trends Microbiol. 2016; 24:477–489. DOI: 10.1016/j.tim.2016.02.010
Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL: Microbial complexes in subgingival plaque. J. Clin. Periodontol. 1998; 25:134–144.
Costalonga M, Herzberg MC: The oral microbiome and the immunobiology of periodontal disease and caries. Immunol. Lett. 2014 162:22–38. DOI: 10.1016/j.imlet.2014.08.017
Hirschfeld J: Dynamic interactions of neutrophils and biofilms. J. Oral. Microbiol. 2014; 6:26102. DOI: 10.3402/jom.v6.26102
Jensen PØ, Bjarnsholt T, Phipps R, Rasmussen TB, Calum H, Christoffersen L, Moser C, Williams P, Pressler T, Givskov M et al: Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum‐sensing‐controlled production of rhamnolipid by Pseudomonas aeruginosa. Microbiology 2007; 153:1329–1338. DOI: 10.1099/mic.0.2006/003863‐0
Bjarnsholt T, Jensen PØ, Burmølle M, Hentzer M, Haagensen JA, Hougen HP, Calum H, Madsen KG, Moser C, Molin S et al: Pseudomonas aeruginosatolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum‐sensing dependent. Microbiology 2005; 151:373–383. DOI: 10.1099/mic.0.27463‐0
Claesson R, Johansson A, Belibasakis G, Hänström L, Kalfas S: Release and activation of matrix metalloproteinase 8 from human neutrophils triggered by the leukotoxin of Actinobacillus actinomycetemcomitans. J. Periodontal. Res. 2002; 37:353–359.
Johansson A, Claesson R, Belibasakis G, Makoveichuk E, Hänström L, Olivecrona G, Sandström G, Kalfas S: Protease inhibitors, the responsible components for the serum‐dependent enhancement of Actinobacillus actinomycetemcomitansleukotoxicity. Eur. J. Oral Sci. 2001; 109:335–341.
Anwar S, Prince LR, Foster SJ, Whyte MK, Sabroe I: The rise and rise of Staphylococcus aureus: laughing in the face of granulocytes. Clin. Exp. Immunol. 2009; 157:216–224. DOI: 10.1111/j.1365‐2249.2009.03950.x
Papo N, Shai Y: A molecular mechanism for lipopolysaccharide protection of Gram‐negative bacteria from antimicrobial peptides. J. Biol. Chem. 2005; 280:10378–10387. DOI: 10.1074/jbc.M412865200
Yamanaka T, Furukawa T, Matsumoto‐Mashimo C, Yamane K, Sugimori C, Nambu T, Mori N, Nishikawa H, Walker CB, Leung KP et al: Gene expression profile and pathogenicity of biofilm‐forming Prevotella intermediastrain 17. BMC Microbiol. 2009; 9:99. DOI: 10.1186/1471‐2180‐9‐11
Gresham HD, Lowrance JH, Caver TE, Wilson BS, Cheung AL, Lindberg FP: Survival of Staphylococcus aureusinside neutrophils contributes to infection. J. Immunol. 2000; 164:3712–3722.
Mydel P, Takahashi Y, Yumoto H, Sztukowska M, Kubica M, Gibson FCr, Kurtz DMJ, Travis J, Collins LV, Nguyen KA et al: Roles of the host oxidative immune response and bacterial antioxidant rubrerythrin during Porphyromonas gingivalisinfection. PLoS Pathog. 2006; 2:e76. DOI: 10.1371/journal.ppat.0020076
Tamura M, Tokuda M, Nagaoka S, Takada H: Lipopolysaccharides of Bacteroides intermedius(Prevotella intermedia) and Bacteroides (Porphyromonas) gingivalis induce interleukin‐8 gene expression in human gingival fibroblast cultures. Infect. Immun. 1992; 11:4932–4937.
Belibasakis GN, Thurnheer T, Bostanci N: Interleukin‐8 responses of multi‐layer gingival epithelia to subgingival biofilms: role of the “red complex” species. PLoS One 2013; 8:e81581. DOI: 10.1371/journal.pone.0081581
Amin M, Grove DA, Kapus A, Glogauer M, Ellen RP: An actin‐stabilizing peptide conjugate deduced from the major outer sheath protein of the bacterium Treponema denticola. Cell Motil. Cytoskeleton 2007; 64:662–674. DOI: 10.1002/cm.20213
Lukac J, Mravak‐Stipetić M, Knezević M, Vrcek J, Sistig S, Ledinsky M, Kusić Z: Phagocytic functions of salivary neutrophils in oral mucous membrane diseases. J. Oral Pathol. Med. 2003; 32:271–274.
Takubo T, Yamane T, Tsuda I, Tagawa S, Tatsumi N: Polymorphonuclear neutrophils in saliva and blood: a comparative study of morphology, function and phenotype. Br. J. Biomed. Sci. 1997 54:260–266.
Hajishengallis G, Maekawa T, Abe T, Hajishengallis E, Lambris JD: Complement involvement in periodontitis: molecular mechanisms and rational therapeutic approaches. Adv. Exp. Med. Biol. 2015; 865:57–74. DOI: 10.1007/978‐3‐319‐18603‐0_4
Maekawa T, Abe T, Hajishengallis E, Hosur KB, DeAngelis RA, Ricklin D, Lambris JD, Hajishengallis G: Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis. J. Immunol. 2014; 192:6020–6027. DOI: 10.4049/jimmunol.1400569
Shin J, Maekawa T, Abe T, Hajishengallis E, Hosur K, Pyaram K, Mitroulis I, Chavakis T, Hajishengallis G: DEL‐1 restrains osteoclastogenesis and inhibits inflammatory bone loss in nonhuman primates. Sci. Transl. Med. 2015; 7:307ra155. DOI: 10.1126/scitranslmed.aac5380